Dr. Arie Goldlust has over 25 years of R&D experience in the medical device, biotechnology and pharmaceutical industries.  Prior to founding Datum Biotech, Dr. Goldlust served for 10 years at ColBar LifeScience, a J&J subsidiary, where he served at different capacities with gradual increase responsibilities. In his last capacity as VP Technology and R&D, Arie led the company's development of two worldwide commercialized collagen based products. He managed all R&D activities supporting the regulatory, clinical, manufacturing, quality and marketing development of those products. He also developed a range of novel tissue engineering scaffolds and led collaborations with different J&J research units in a variety of other biomaterial projects.  Prior to joining Colbar, Arie was Manager of Process Development and Protein Research at CBD Technologies, Ltd and before that, he held a research position at the Department of Process Development of Biotechnology General.  Dr. Goldlust received his Ph.D and M.Sc. degrees in biochemistry from the Weizmann Institute of Science, Rehovot, Israel and his B.Sc. degree from the Hebrew University of Jerusalem.. He completed his post‐doctoral training at the Department of Biological‐Chemistry, University of Michigan Medical School, Ann Arbor, Michigan USA and at the Department of Biotechnology, Parke‐Davis Pharmaceutical‐Research Division of Warner‐Lambert Company, Ann Arbor, Michigan USA.

 Dental, Dentists, Dentistry, Implant Dentistry